Cleared Traditional

K240627 - LIAISON PLEX Yeast Blood Culture Assay

K240627 is an FDA 510(k) clearance for LIAISON PLEX Yeast Blood Culture Assay, manufactured by Luminex Corporation. The device is a Class 2 Microbiology device with product code PEO cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K240627 · Luminex Corporation · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
90d
Days
Class 2
Risk

K240627 is an FDA 510(k) clearance for the LIAISON PLEX Yeast Blood Culture Assay. Classified as Fungal Organisms, Nucleic Acid-based Assay (product code PEO), Class II - Special Controls.

Submitted by Luminex Corporation (Northbrook, US). The FDA issued a Cleared decision on June 4, 2024 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3365 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Luminex Corporation devices

FDA 510(k) Submission Details - K240627

510(k) Number K240627 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2024
Decision Date June 04, 2024
Days to Decision 90 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 102d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PEO Device Classification - Class 2, Special Controls

Product Code PEO Fungal Organisms, Nucleic Acid-based Assay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3365
Definition A Qualitative Multiplexed In Vitro Diagnostic Device To Detect And Identify Fungal Organisms In Positive Blood Cultures.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.